The legacy of the COVID-19 pandemics for thyroid cancer patients: towards the application of clinical practice recommendations
Endocrine
.
2023 Jan;79(1):45-48.
doi: 10.1007/s12020-022-03132-6.
Epub 2022 Jul 20.
Authors
Giorgio Grani
1
,
Laura Ciotti
1
,
Valeria Del Gatto
1
,
Teresa Montesano
1
,
Marco Biffoni
2
,
Laura Giacomelli
2
,
Marialuisa Sponziello
1
,
Valeria Pecce
1
,
Antonella Verrienti
1
,
Sebastiano Filetti
3
,
Cosimo Durante
4
Affiliations
1
Department of Translational and Precision Medicine, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy.
2
Department of Surgical Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy.
3
School of Health, UNITELMA Sapienza University of Rome, Piazza Sassari, 4, 00161, Rome, Italy.
4
Department of Translational and Precision Medicine, Sapienza University of Rome, Viale del Policlinico 155, 00161, Rome, Italy.
[email protected]
.
PMID:
35857273
PMCID:
PMC9298162
DOI:
10.1007/s12020-022-03132-6
No abstract available
MeSH terms
COVID-19*
Humans
Pandemics
SARS-CoV-2
Thyroid Neoplasms* / epidemiology
Thyroid Neoplasms* / therapy